Insider Transactions in Q4 2023 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 26
2023
|
Frank Mccormick |
SELL
Open market or private sale
|
Indirect |
100,000
-13.74%
|
$4,200,000
$42.06 P/Share
|
|
Dec 18
2023
|
Randal W. Scott |
SELL
Open market or private sale
|
Indirect |
2,000
-18.18%
|
$80,000
$40.0 P/Share
|
|
Dec 15
2023
|
Hannah Valantine |
SELL
Open market or private sale
|
Direct |
2,915
-62.3%
|
$104,940
$36.12 P/Share
|
|
Dec 15
2023
|
Hannah Valantine |
BUY
Exercise of conversion of derivative security
|
Direct |
2,915
+38.39%
|
$23,320
$8.45 P/Share
|
|
Dec 01
2023
|
Randal W. Scott |
SELL
Open market or private sale
|
Indirect |
2,500
-9.7%
|
$72,500
$29.25 P/Share
|
|
Nov 17
2023
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
51,552
-0.53%
|
$1,495,008
$29.33 P/Share
|
|
Nov 17
2023
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Open market or private sale
|
Direct |
22,685
-38.19%
|
$657,865
$29.1 P/Share
|
|
Nov 16
2023
|
Charles J Homcy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,301
-0.11%
|
$36,428
$28.86 P/Share
|
|
Nov 16
2023
|
Charles J Homcy |
BUY
Exercise of conversion of derivative security
|
Direct |
3,760
+0.31%
|
-
|
|
Nov 16
2023
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
50,697
-1.03%
|
$1,419,516
$28.86 P/Share
|
|
Nov 16
2023
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
102,249
+2.04%
|
-
|
|
Nov 16
2023
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,311
-27.31%
|
$624,708
$28.86 P/Share
|
|
Nov 16
2023
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,996
+35.51%
|
-
|
|
Nov 15
2023
|
Hannah Valantine |
SELL
Open market or private sale
|
Direct |
2,915
-62.3%
|
$87,450
$30.0 P/Share
|
|
Nov 15
2023
|
Hannah Valantine |
BUY
Exercise of conversion of derivative security
|
Direct |
2,915
+38.39%
|
$23,320
$8.45 P/Share
|